Novel cell therapy is a technique which involves replacing diseased or dysfunctional cells with healthy functioning.
“Global Cell Therapy Market Outlook, Patent & Clinical Trials Insight 2028" Report Highlights:
- Global Cell Therapy Market Opportunity: > USD 45 Billion By 2028
- Cell Therapy Clinical Trial Insight by Indication, Company and Country
- Insight On More than 1600 Cell Therapies in Clinical Trials
- Clinical & Commercial Insight On 32 Cell Therapies Available in Market
- Dosage & Pricing Insight By Country & Region
- COVID-19 Impact Analysis on Global market & Clinical Trials
- Price & Product Insight By Region/Country
Download Report:
Novel cell therapy is a technique which involves replacing diseased or dysfunctional cells with healthy functioning. Stem cells are the most frequently used in cellular therapies owing to their ability to differentiate into specific cells required for repairing damaged or defective tissues or cells. Apart from this, cells such as blood and bone marrow cells, mature, immature & solid tissue cells, adult stem cells, and embryonic stem cells are widely used in cell therapy procedures. To date, several cellular therapies have been marketed for the management of wide range of diseases and have shown robust response.
Recently, the advancement in the field of immunotherapy and subsequent utilization of T-cell to target cancer cells has gained considerable interest in the market. The advent of chimeric antigen receptor (CAR) T-cell therapy has greatly revolutionized the overall cellular therapies market. As of now, five chimeric antigen receptor T-cell therapies have been approved for the management of cancers and have shown to significantly improve the survival outcomes in patients. The robust response of the CAR T-cell has encouraged further research and development in this sector, which will further propel the growth of market during the forecast period.
The emergence of new technologies has further supported the development of advanced cellular therapies. For instance, Gamma delta T-cells have emerged as attractive candidate for adoptive T-cell immunotherapies due to their unique biology and potential benefits in comparison to conventional T-cell based immunotherapies. Currently, these are majorly present in initial stage of clinical development and are expected to enter the market during the forecast period. Apart from this, researchers are also validating several combinational approaches to enhance efficacy. For instance, collaboration between Imugene and Eureka Therapeutics is evaluating CD19 oncolytic virus onCARlytics technology in combination with anti-CD19 ARTEMIS® T-cell therapy for the treatment of solid tumours.
The cell therapy market is highly competitive and consists of several players including Celgene, Omnicyte, Pharmicell, Baxter Healthcare Corporation, Cell medica, and several others. The pharmaceutical and biotech compaies are opening their doors towards mergers and acquisitions alongside showing their willingness to enter into partnerships. One of the main aims behind this intention is to win a competitive edge over the competitiors in the international market. For instance, in November 2021, Secarna Pharmaceuticals and Achilles Therapeutics have partnered to optimize the development of T-cell therapies.
The global cell therapy market is mainly driven by the large number of clinical studies of cell based therapies which can be attributed to the presence of government and private funding agencies that are constantly offering grants to support projects across various stages of clinical trials. Further, US is estimated to retain the largest share of the cell therapy market due to the presence of a strong regulatory framework to promote cellular therapy development, the existence of industry key players, and the presence of leading universities that supports the research activities in the region. Factors attributing to the high growth of the studied market in the region include the increasing prevalence of chronic conditions, rising adoption of regenerative medicine, and rise in the number of clinical studies about the development of cellular therapies.
The curated report Global Cell therapy market aims to provide a deep discussion on the currently available cell therapies along with their pricing, dosage, and patent analysis. By geography, the market is segmented into US, South Korea, Europe, Japan, China, and rest of world. Also, the report is a clear depiction of the rising competition amongst the key market players and the aim is to consider the recent developments undertaken during the ongoing forecast period that ends in 2026.
Contact:
Neeraj Chawla
Kuick Research
Research Head
+91-9810410366